|
|
|
|
|
|
 |
 |
|
|
 |
|
IP Law360
|
 |
|
 |
Don Johnson 'Nash Bridges' Award Jumps To $52M
A California judge has granted Don Johnson interest on unpaid profits from the television show “Nash Bridges,” more than doubling the actor's take in his dispute with his co-producer to nearly $52 million.
Stauffer Paves Way For New False Marking Defenses
While the U.S. Court of Appeals for the Federal Circuit’s Stauffer ruling is not going to deter individual plaintiffs from taking their false patent marking suits to the courthouse, it gives defendants a few extra arguments that could help knock out cases earlier, experts say.
USPTO Cutting Into Patent App Backlog: Kappos
Despite an expected 4 percent increase in patent filings in 2010, the U.S. Patent and Trademark Office is on pace to achieve its first significant reduction in patent application backlogs in a decade, Director David Kappos said Wednesday.
Sandoz Can't Escape Teva's Copaxone Patent Suit
Sandoz Inc. and Momenta Pharmaceuticals Inc. have lost their bid to upend Teva Pharmaceuticals USA Inc.'s suit accusing the generic-drug makers of infringing several patents in their effort to manufacture a copycat version of multiple sclerosis drug Copaxone.
Gucci Relatives Could Pay $2M In Trademark Suit
A magistrate judge has recommended that the daughter and ex-wife of a former Gucci America Inc. executive, as well as their business partner, pay $1.9 million in damages and attorneys' fees to the high-end brand for allegedly infringing the Gucci trademark.
Fed. Circ. Revives Synthetic Mulch Patent
A federal appeals court has overturned a decision that Green Edge Enterprises LLC's synthetic mulch patent is invalid for violation of the best mode requirement.
Fed. Circ. Reverses Patent Priority Rulings On Protein
A federal appeals court has ruled that a patent application must do more than simply allow someone skilled in a field to envision an invention in order to lay claim to priority to the technology, reversing two interference decisions over an antiviral protein.
Purdue To Pay $16M To Settle OxyContin Claims
Purdue Pharma LP has agreed to pay $16 million to settle claims by direct purchasers of OxyContin that the drugmaker filed bogus patent litigation to crush generic competition.
Bilski Decision Kills Vraston's Suit Over Trading Patent
A federal judge has dismissed Vraston Trading Inc.'s suit against several major stock exchanges over a patent covering the trading of exchange-traded funds, saying the patent is not enforceable in light of the U.S. Supreme Court's decision in Bilski v. Kappos.
Online Gaming Patent Suit V. Sony Remains In Texas
PalTalk Holdings Inc.'s suit accusing Sony Corp. and others of infringing two patents related to interactive online game play will remain in the U.S. District Court for the Eastern District of Texas, a federal judge has ruled, citing his own familiarity with the technology involved.
$3.4M Torts Verdict Against Otis Upheld
A Massachusetts appeals court has affirmed a $3.35 million jury verdict against Otis Elevator Co. stemming from injuries caused by an escalator made by a Chinese joint venture that had licensed Otis' trademarks.
ITC Probes Samsung, Others In Spansion 337 Case
The U.S. International Trade Commission has opened up an investigation into whether Samsung Electronics Co. Ltd. and others infringed Spansion Inc.’s flash memory chip patents.
Eminem's Label Wins Appeal Of Digital Royalties Loss
A federal appeals court has overturned a win for UMG Recording Inc. in a royalties dispute with rapper Eminem's former production company, finding that licensing songs to online sellers for resale should be considered the same as the licensing a song to a television show.
2nd Circ. Won't Rehear Cipro Pay-For-Delay Suit
A federal appeals court has rejected an en banc rehearing bid from drug purchasers who said a settlement Bayer AG struck with Barr Laboratories Inc. in patent litigation over the antibiotic Cipro violated antitrust law.
HP Tries To Block Former CEO's Move To Oracle
Hewlett-Packard Co. has filed a trade secrets and breach of contract suit against recently departed CEO Mark Hurd, in an effort to keep him from joining rival technology giant Oracle Corp. as co-president.
3 IP Groups Are Tops For In-House Counsel
When corporate counsel are facing a daunting intellectual property litigation matter, there are three firms they most want to have on their side, according to a new survey.
Estee Lauder, Oxis Resolve Antioxidant Patent Suit
Estee Lauder Cos. Inc. has resolved a decades-long dispute with Oxis International over patents relating to a molecule with antioxidant properties.
Ravens On Hook For Some Logo IP Claims
A federal appeals court has ruled that the National Football League’s Baltimore Ravens cannot completely hide behind a fair use defense in a suit brought by the designer of their original logo, who claims the team has been unlawfully profiting from unauthorized copying of his image.
T-Mobile Exits Dicam Cell Phone Patent Suit
Dicam Inc. has agreed to drop T-Mobile USA Inc. from a patent infringement suit against Sprint Nextel Corp., Sanyo North America Corp. and other cell phone companies over a personal security system.
Radio Flyer Sued For Using Expired Patent
Radio Flyer Inc.’s eye-catching bright red wagons have attracted attention from Promote Innovation LLC, a qui tam plaintiff alleging the toy company marks its iconic wagons with an expired patent.
|
|
|
 |
|
|
|
|
|
|
|
|